Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, Nov. 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0685949/Pacemakers-and-Cardiac-Resynchronization-Therapy-Pacemakers-CRT-P---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices
Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides the market landscape, competitive landscape and market trend information on the pacemakers and cardiac resynchronization therapy-pacemakers markets. The report provides comprehensive information on the key trends affecting the market and key analytical content on the market's dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include dual chamber and single chamber pacemakers and cardiac resynchronization therapy-pacemakers.
- Annualized market revenues data from 2003 to 2010, forecast to 2017 and company share data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints within the pacemakers and cardiac resynchronization therapy pacemakers market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, St. Jude Medical, BIOTRONIK and Sorin Group.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the pacemakers and cardiac resynchronization therapy pacemakers market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the pacemakers and cardiac resynchronization therapy-pacemakers market landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global pacemakers and cardiac resynchronization therapy pacemakers market and the factors shaping it.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction and Overview 11
2.1 Introduction 11
2.2 GlobalData Report Guidance 11
3 Disease Overview: Cardiac Arrythmia and Congestive Heart Failure (CHF) 12
3.1 Cardiac Arrhythmia 12
3.1.1 Bradycardia 12
3.1.2 Fibrillation 13
3.2 Congestive Heart Failure (CHF) 14
3.2.1 Epidemiology 14
3.3 Diagnosis of Cardiac Arrythmia and Congestive Heart Failure 15
3.3.1 Electrocardiography (ECG) 15
3.3.2 Echocardiogram 15
3.3.3 Holter Monitor (or Continuous Ambulatory Electrocardiographic Monitor) 15
3.3.4 Trans-Telephonic Monitor (Event Recorder) 15
3.3.5 Treadmill Testing 15
3.3.6 Tilt Table Studies 15
3.3.7 Electro-Physiologic Testing 15
3.3.8 Trans-Thoracic Echocardiography (TTE) and Echocardiography 15
3.3.9 Intra-Cardiac Electro-Physiologic Procedure 15
3.3.10 Cardiac Catheterization 16
3.3.11 B-Type Natriuretic Peptide (BNP) Level Test 16
3.4 Treatment Options for Cardiac Arrythmia and Congestive Heart Failure 16
3.4.1 Lifestyle Changes 16
3.4.2 Medications 16
3.4.3 Invasive Therapies 16
4 Device Overview 17
4.1 Pacemakers 17
4.1.1 Pacemaker Design 17
4.1.2 Risk Factors Associated with Pacemakers 18
4.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) 18
4.2.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Design 18
4.2.2 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) Risk Factors 18
4.3 Devices Interfering with the Working of Pacemaker and Cardiac Resynchronization Therapy-Pacemakers (CRT-P) 18
5 Global Pacemakers and Cardiac Resynchronization Therapy-Pacemakers: Market Characterization 19
5.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Historic, 2003-2010 19
5.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), Forecast, 2010-2017 20
5.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Key Trend 21
5.3.1 Single Chamber Pacemakers Registered Higher Sales than Dual Chamber Pacemakers in Developing Economies 21
5.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics 23
5.4.1 Market Drivers 23
5.4.2 Market Restraints 33
6 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Analysis by Country, Revenue ($m), 2010-2017 41
6.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Historic, 2003-2010 42
6.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), Forecast, 2010-2017 43
6.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Historic, 2003-2010 44
6.4 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), Forecast, 2010-2017 45
6.5 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Historic, 2003-2010 46
6.6 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), Forecast, 2010-2017 47
6.7 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Historic, 2003-2010 48
6.8 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), Forecast, 2010-2017 49
6.9 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Historic, 2003-2010 50
6.10 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), Forecast, 2010-2017 51
6.11 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Historic, 2003-2010 52
6.12 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), Forecast, 2010-2017 53
6.13 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Historic, 2003-2010 54
6.14 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), Forecast, 2010-2017 55
6.15 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Historic, 2003-2010 56
6.16 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), Forecast, 2010-2017 57
6.17 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Historic, 2003-2010 58
6.18 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), Forecast, 2010-2017 59
6.19 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Historic, 2003-2010 60
6.20 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), Forecast, 2010-2017 61
6.21 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Historic, 2003-2010 62
6.22 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), Forecast, 2010-2017 63
6.23 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Historic, 2003-2010 64
6.24 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), Forecast, 2010-2017 65
7 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market: Strategic Competitive Assessment 66
7.1 Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants 67
7.1.1 Medtronic Inc. 67
7.1.2 St. Jude Medical 72
7.1.3 BIOTRONIK Inc. GMBH 73
7.1.4 Boston Scientific 75
7.1.5 Sorin S.p.A 77
8 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Key Marketed Products 80
8.1 Adapta, Dual Chamber Pacemaker, Medtronic Inc. 80
8.1.1 Features and Benefits 80
8.2 EnRythm, Dual Chamber Pacemaker, Medtronic Inc. 81
8.2.1 Features and Benefits 81
8.3 Revo MRI SureScan, MRI Safe Dual Chamber Pacemaker, Medtronic Inc. 81
8.3.1 Features and Benefits 81
8.4 Advisa MRI SureScan Pacemaker, Dual Chamber MRI Safe Pacemaker, Medtronic Inc. 82
8.4.1 Features and Benefits 82
8.5 Accent Wireless Single/Dual Chamber Pacemaker, St. Jude Medical 82
8.5.1 Features and Benefits 82
8.6 Entity Dual Chamber Pacemaker, St. Jude Medical 83
8.6.1 Features and Benefits 83
8.7 Affinity Dual Chamber Pacemaker, St. Jude Medical 83
8.7.1 Features and Benefits 83
8.8 Identity ADx Dual Chamber Pacemaker, St. Jude Medical 84
8.8.1 Features and Benefits 84
8.9 Verity ADx Dual Chamber Pacemaker, St. Jude Medical 84
8.9.1 Features and Benefits 84
8.10 Regency Single Chamber Pacemaker, St. Jude Medical 85
8.10.1 Features and Benefits 85
8.11 Microny Single Chamber Pacemaker, St. Jude Medical 85
8.11.1 Features and Benefits 85
8.12 Integrity ADx Dual Chamber Pacemaker, St. Jude Medical 85
8.12.1 Features and Benefits 85
8.13 Altrua Group of Single/Dual Chamber Pacemaker, Boston Scientific 86
8.13.1 Features and Benefits 86
8.14 ProMRI MRI Safe Single/Dual Chamber Pacemaker, BIOTRONIK 86
8.14.1 Features and Benefits 86
8.15 Evia Single/Dual Chamber Pacemaker, BIOTRONIK 87
8.15.1 Features and Benefits 87
8.16 Effecta Dual Chamber Pacemaker, BIOTRONIK 87
8.16.1 Features and Benefits 87
8.17 Consulta, Medtronic Inc. 87
8.17.1 Features and Benefits 88
8.18 Syncra, Medtronic Inc. 88
8.18.1 Features and Benefits 88
8.19 Frontier-II, St. Jude Medical 89
8.19.1 Features and Benefits 89
8.20 Stratos LV-T, BIOTRONIK 89
8.20.1 Features and Benefits 89
9 Pacemakers Market: Strategic Pipeline Assessment 90
9.1 Pacemakers in Clinical Development Stage 90
9.1.1 Advisa DR MRI SureScan Pacing System, Medtronic, Inc. 91
9.1.2 ECN Pacemaker, Mathematical Bio-Solutions, Inc. 92
9.1.3 Reply MRI Pacemaker, Sorin Group 92
9.1.4 Ensura MRI SureScan Pacing System, Medtronic, Inc. 94
9.1.5 Unconditional MRI Compatible Implantable Pacemaker, Kenergy Inc. 94
9.1.6 Accent MRI Pacemaker, St. Jude Medical 95
9.1.7 INGENIO 2 PG - MICS, Boston Scientific Corporation 95
9.2 Pacemaker in Early Development Stage 95
9.2.1 MicroPort Pacemaker, MicroPort Scientific Corporation 95
9.3 Pacemakers in Approval Phase 96
9.3.1 INGENIO Pacemaker System NG, Boston Scientific Corporation 96
9.4 Pacemakers in Pre-Clinical Development Stage 97
9.4.1 Aortic Pacemaker 97
10 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Strategic Deals Analysis 98
10.1 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Venture Financing Deals, 2006-2010 99
10.2 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Mergers and Acquisitions, 2006-2011 100
10.3 Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Partnerships, 2006-2011 100
10.4 Key Deals 101
10.4.1 LETI Forms Partnership with Sorin, TIMA, Cedrat Technologies, Tronics and EASII IC 101
10.4.2 St. Jude Medical to Invest in Nanostim 101
10.4.3 Boston Scientific Enters into an Agreement with Fukuda Denshi 101
10.4.4 MediVed to Secure $5m in Second Round of Financing 102
11 Appendix 103
11.1 Market Definitions 103
11.1.1 Pacemakers 103
11.1.2 Cardiac Resynchronisation Therapy-Pacemakers 104
11.2 Acronyms 104
11.3 Sources 106
11.4 Research Methodology 106
11.4.1 Secondary Research 106
11.4.2 Primary Research 107
11.4.3 Models 107
11.4.4 Forecasts 107
11.4.5 Expert Panels 107
11.5 GlobalData Consulting 108
11.6 Contact Us 108
11.7 Disclaimer 108
List of Tables
Table 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010 19
Table 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017 20
Table 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010 21
Table 4: Percentage of Overweight and Obese Population (Aged 15 Years and Above), Global, 2010 24
Table 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010 25
Table 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010 26
Table 7: Percentage of Smoking Population, Global, 2010 27
Table 8: Percentage of Population aged 65 Years and Older, by Country, 2005-2015 28
Table 9: Emerging Market Contribution, Global, 2009-2010 29
Table 10: Demand versus Supply, Developing Economies, 2009 30
Table 11: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010 30
Table 12: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 35
Table 13: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 35
Table 14: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 36
Table 15: Deference of Healthcare Services, The US, 2006-2009 37
Table 16: Cardiac Rhythm Management Market, List of Device Recalls, 2004-2010 38
Table 17: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010 39
Table 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR (2010-2017) 41
Table 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010 42
Table 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017 43
Table 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010 44
Table 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017 45
Table 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010 46
Table 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017 47
Table 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010 48
Table 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017 49
Table 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010 50
Table 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017 51
Table 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010 52
Table 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017 53
Table 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010 54
Table 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017 55
Table 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010 56
Table 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017 57
Table 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010 58
Table 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017 59
Table 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010 60
Table 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017 61
Table 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010 62
Table 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017 63
Table 41: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010 64
Table 42: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017 65
Table 43: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010 66
Table 44: Adapta, Features and Benefits 80
Table 45: EnRythm, Features and Benefits 81
Table 46: Revo MRI SureScan, Features and Benefits 81
Table 47: Advisa MRI SureScan Pacemaker, Features and Benefits 82
Table 48: Accent Wireless Single / Dual Chamber Pacemaker, Features and Benefits 82
Table 49: Entity Dual Chamber Pacemaker, Features and Benefits 83
Table 50: Affinity, Features and Benefits 83
Table 51: Identity ADx, Features and Benefits 84
Table 52: Verity ADx, Features and Benefits 84
Table 53: Regency, Features and Benefits 85
Table 54: Microny, Features and Benefits 85
Table 55: Integrity ADx, Features and Benefits 85
Table 56: Altrua, Features and Benefits 86
Table 57: ProMRI, Features and Benefits 86
Table 58: Evia, Features and Benefits 87
Table 59: Effecta, Features and Benefits 87
Table 60: Consulta, Features and Benefits 88
Table 61: Syncra, Features and Benefits 88
Table 62: Frontier-II, Features and Benefits 89
Table 63: Stratos LV-T, Features and Benefits 89
Table 64: List of Pacemaker in Clinical Development Stage 90
Table 65: Advisa DR MRI SureScan Pacing System, Status 91
Table 66: Advisa DR MRI SureScan Pacing System, Clinical Trial 91
Table 67: Aortic Pacemaker, Status 92
Table 68: Reply MRI Pacemaker, Product Status 92
Table 69: Reply MRI Pacemaker, Clinical Trial 93
Table 70: Ensura MRI SureScan, Status 94
Table 71: Unconditional MRI Compatible Implantable Pacemaker, Status 94
Table 72: Accent MRI Pacemaker, Status 95
Table 73: INGENIO 2 PG - MICS , Status 95
Table 74: List of Pacemaker in Early Development Stage 95
Table 75: MicroPort Pacemaker, Status 96
Table 76: List of Pacemaker in Approval Phase 96
Table 77: INGENIO Pacemaker System NG, Status 96
Table 78: List of Pacemaker in Pre-Clinical Development Stage 97
Table 79: Aortic Pacemaker, Status 97
Table 80: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market 98
Table 81: Pacemaker Market, Venture Financing Deals, 2006-2010 99
Table 82: Pacemaker, Mergers and Acquisitions, 2006-2011 100
Table 83: Pacemaker Market, Partnerships, 2006-2011 100
List of Figures
Figure 1: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2003-2010 19
Figure 2: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Revenue ($m), 2010-2017 20
Figure 3: Single Chamber Pacemakers versus Dual Chamber Pacemakers, Sales Volume Comparison, by Country, 2010 21
Figure 4: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers, Market Dynamics 23
Figure 5: Diabetes Prevalence Rates, 20-79 Years, by Region, 2007-2010 25
Figure 6: Percentage of Hypertensive Population (25 Years and Above), Global, 2010 26
Figure 7: Percentage of Population Aged 65 Years and Above, by Country, 2005-2015 28
Figure 8: Emerging Market Contribution, Global, 2009-2010 29
Figure 9: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market Revenue ($m) and Growth (%) Comparison, by Country, 2006-2010 30
Figure 10: Evolution in Pacemaker Technology and its Impact on the Market 32
Figure 11: Dual Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 34
Figure 12: Single Chamber Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 35
Figure 13: Cardiac Resynchronization Therapy-Pacemakers, Average Selling Price ($) Comparison, Developed Economies, 2008-2010 36
Figure 14: Average Selling Price Comparison ($), Dual Chamber Pacemakers, by Country, 2010 39
Figure 15: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Global, Analysis by Country, Revenue ($m) and Forecast CAGR(2010-2017) 41
Figure 16: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2003-2010 42
Figure 17: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The US, Revenue ($m), 2010-2017 43
Figure 18: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2003-2010 44
Figure 19: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Canada, Revenue ($m), 2010-2017 45
Figure 20: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2003-2010 46
Figure 21: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, The UK, Revenue ($m), 2010-2017 47
Figure 22: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2003-2010 48
Figure 23: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Germany, Revenue ($m), 2010-2017 49
Figure 24: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2003-2010 50
Figure 25: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, France, Revenue ($m), 2010-2017 51
Figure 26: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2003-2010 52
Figure 27: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Italy, Revenue ($m), 2010-2017 53
Figure 28: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2003-2010 54
Figure 29: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Spain, Revenue ($m), 2010-2017 55
Figure 30: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2003-2010 56
Figure 31: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Japan, Revenue ($m), 2010-2017 57
Figure 32: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2003-2010 58
Figure 33: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, China, Revenue ($m), 2010-2017 59
Figure 34: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2003-2010 60
Figure 35: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, India, Revenue ($m), 2010-2017 61
Figure 36: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2003-2010 62
Figure 37: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Australia, Revenue ($m), 2010-2017 63
Figure 38: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2003-2010 64
Figure 39: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Brazil, Revenue ($m), 2010-2017 65
Figure 40: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Company Share (%), 2010 66
Figure 41: Pacemaker and Cardiac Resynchronization Therapy-Pacemakers, Key Market Participants Presence in Market Segments, 2010 67
Figure 42: Medtronic Inc., SWOT Analysis 68
Figure 43: St. Jude Medical, Inc., SWOT Analysis 72
Figure 44: BIOTRONIK , SWOT Analysis 74
Figure 45: Boston Scientific, SWOT Analysis 75
Figure 46: Sorin S.p.A, SWOT Analysis 78
Figure 47: Pacemakers Market, Global Pipeline Products 90
Figure 48: Pacemakers and Cardiac Resynchronization Therapy-Pacemakers Market, Deals, 2006-2011 98
Companies Mentioned
Medtronic Inc.
St. Jude Medical
BIOTRONIK Inc. GMBH
Boston Scientific
Sorin S.p.A
To order this report:
Cardiovascular Devices Industry: Pacemakers and Cardiac Resynchronization Therapy Pacemakers (CRT-P) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article